Role of pancreatic beta-cells in the process of beta-cell death. 2001

D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
Diabetes Research Center, Vrije Universiteit Brussel, Belgium. daniel.pipeleers@vub.ac.be

Studies on the pathogenesis of type 1 diabetes have mainly focused on the role of the immune system in the destruction of pancreatic beta-cells. Lack of data on the cellular and molecular events at the beta-cell level is caused by the inaccessibility of these cells during development of the disease. Indirect information has been collected from isolated rodent and human islet cell preparations that were exposed to cytotoxic conditions. This article reviews in vitro experiments that investigated the role of beta-cells in the process of beta-cell death. beta-Cells rapidly die in necrosis because of toxic levels of oxidizing radicals or of nitric oxide; they progressively become apoptotic after prolonged culture at low glucose or with proinflammatory cytokines. Their susceptibility to necrosis or apoptosis varies with their functional state and thus with the environmental conditions. A change in cellular phenotype can alter its recognition of potentially cytotoxic agents and its defense mechanisms against cell death. These observations support the view that beta-cells are not necessarily passive victims of a cytotoxic process but can actively participate in a process of beta-cell death. Their role will be influenced by neighboring non-beta-cells, which can make the islet internal milieu more protective or toxic for the beta-cells. We consider duct cells as potentially important contributors to this local process.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010183 Pancreatic Ducts Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM. Duct of Santorini,Duct of Wirsung,Duodenal Papilla, Minor,Wirsung's Duct,Accessory Pancreatic Duct,Accessory Pancreatic Duct of Santorini,Main Pancreatic Duct,Santorini's Duct,Accessory Pancreatic Ducts,Duct, Accessory Pancreatic,Duct, Main Pancreatic,Duct, Pancreatic,Duct, Santorini's,Duct, Wirsung's,Ducts, Pancreatic,Main Pancreatic Ducts,Minor Duodenal Papilla,Minor Duodenal Papillas,Pancreatic Duct,Pancreatic Duct, Accessory,Pancreatic Duct, Main,Pancreatic Ducts, Accessory,Papilla, Minor Duodenal,Santorini Duct,Wirsung Duct,Wirsungs Duct
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
February 2001, Diabetes,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
January 2024, Endocrine, metabolic & immune disorders drug targets,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
June 2010, Molecular and cellular endocrinology,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
January 2021, Frontiers in endocrinology,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
August 2004, Journal of cellular physiology,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
January 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
July 1995, Diabetes,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
November 2000, Trends in endocrinology and metabolism: TEM,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
April 2010, American journal of physiology. Endocrinology and metabolism,
D Pipeleers, and A Hoorens, and M Marichal-Pipeleers, and M Van de Casteele, and L Bouwens, and Z Ling
January 2007, Clinical science (London, England : 1979),
Copied contents to your clipboard!